| Dr Jordan E Scott, MD | |
|
79 Erdman Way, Suite 101, Leominster, MA 01453 | |
| (978) 537-4805 | |
| (978) 537-2185 |
| Full Name | Dr Jordan E Scott |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 24 Years |
| Location | 79 Erdman Way, Leominster, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275517245 | NPI | - | NPPES |
| 2119552 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 214922 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Heywood Hospital - | Gardner, MA | Hospital |
| Winchester Hospital | Winchester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Physicians Pc | 6103859103 | 4 |
| Northeast Allergy, Asthma And Immunology, Pc | 2860529203 | 8 |
News Archive
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Researchers at The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) and UMDNJ-Robert Wood Johnson Medical School (UMDNJ-RWJMS) have completed a study that pinpoints the period between 24 and 32 months of age as most effective time frame for parents to begin toilet training lessons with their children.
› Verified 4 days ago
| Entity Name | Allergy & Asthma Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326030206 PECOS PAC ID: 6103859103 Enrollment ID: O20050912000173 |
News Archive
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Researchers at The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) and UMDNJ-Robert Wood Johnson Medical School (UMDNJ-RWJMS) have completed a study that pinpoints the period between 24 and 32 months of age as most effective time frame for parents to begin toilet training lessons with their children.
› Verified 4 days ago
| Entity Name | Northeast Allergy, Asthma & Immunology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972835809 PECOS PAC ID: 2860529203 Enrollment ID: O20100416000306 |
News Archive
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Researchers at The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) and UMDNJ-Robert Wood Johnson Medical School (UMDNJ-RWJMS) have completed a study that pinpoints the period between 24 and 32 months of age as most effective time frame for parents to begin toilet training lessons with their children.
› Verified 4 days ago
| Entity Name | Northeast Allergy - Bi Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588308803 PECOS PAC ID: 7416327895 Enrollment ID: O20221229000413 |
News Archive
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Researchers at The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) and UMDNJ-Robert Wood Johnson Medical School (UMDNJ-RWJMS) have completed a study that pinpoints the period between 24 and 32 months of age as most effective time frame for parents to begin toilet training lessons with their children.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jordan E Scott, MD 79 Erdman Way, Suite 101, Leominster, MA 01453 Ph: (978) 537-4805 | Dr Jordan E Scott, MD 79 Erdman Way, Suite 101, Leominster, MA 01453 Ph: (978) 537-4805 |
News Archive
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Researchers at The Bristol-Myers Squibb Children's Hospital (BMSCH) at Robert Wood Johnson University Hospital (RWJUH) and UMDNJ-Robert Wood Johnson Medical School (UMDNJ-RWJMS) have completed a study that pinpoints the period between 24 and 32 months of age as most effective time frame for parents to begin toilet training lessons with their children.
› Verified 4 days ago
Francisco A Bonilla, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 79 Erdman Way, Ste 101, Leominster, MA 01453 Phone: 617-355-8594 Fax: 617-730-0310 | |
David E. Riester, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 79 Erdman Way, Suite 101, Leominster, MA 01453 Phone: 978-537-4805 Fax: 978-537-2185 | |
Dr. Geraldine Feldman, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 50 Memorial Dr, Ste 206, Leominster, MA 01453 Phone: 978-537-4805 Fax: 978-537-2185 | |
John M. O'loughlin, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 80 Erdman Way, Suite 315., Leominster, MA 01453 Phone: 978-537-4805 Fax: 978-537-2185 | |
Dr. Tracy Lynn Kruzick, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 80 Erdman Way Ste 315, Leominster, MA 01453 Phone: 978-537-4805 |